Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.
The maturation and envelopment of varicella-zoster virus (VZV) was studied in infected human embryonic lung fibroblasts. Transmission electron microscopy confirmed that nucleocapsids acquire an envelope from the inner nuclear membrane as they enter the perinuclear-cisterna-rough endoplasmic reticulum (RER). Tegument is not detectable in these virions; moreover, in contrast to the mature VZV envelope, the envelope of VZV in the RER is not radioautographically labeled in pulse-chase experiments with [3H]mannose, and it lacks gpI immunoreactivity and complex oligosaccharides. This primary envelope fuses with the RER membrane (detected in cells incubated at 20 degrees C), thereby releasing nucleocapsids to the cytosol. Viral glycoproteins, traced by transmission electron microscopy radioautography in pulse-chase experiments with [3H]mannose, are transported to the trans-Golgi network (TGN) by a pathway that runs from the RER through an intermediate compartment and the Golgi stack. At later chase intervals, [3H]mannose labeling becomes associated with enveloped virions in post-Golgi locations (prelysosomes and plasma membrane). Nucleocapsids appear to be enveloped by wrapping in specialized cisternae, identified as the TGN with specific markers. Tegument-like material adheres to the cytosolic face of the concave surface of TGN sacs; nucleocapsids adhere to this protein, which is thus trapped between the nucleocapsid and the TGN-derived membrane that wraps around it. Experiments with brefeldin A suggest that tegument may bind to the cytosolic tails of viral glycoproteins. Fusion and fission convert the TGN-derived wrapping sacs into an inner enveloped virion and an outer transport vesicle that carries newly enveloped virions to cytoplasmic vacuoles. These vacuoles are acidic and were identified as prelysosomes. It is postulated that secreted virions are partially degraded by their exposure to the prelysosomal internal milieu and rendered noninfectious. This process explains the cell-associated nature of VZV in vitro; however, the mechanism by which the virus escapes diversion from the secretory pathway to the lysosomal pathway in vivo remains to be determined.
Gershon
A A
AA
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Sherman
D L
DL
Zhu
Z
Z
Gabel
C A
CA
Ambron
R T
RT
Gershon
M D
MD
D002460:Cell Line; D002462:Cell Membrane / Q000382:microbiology / Q000648:ultrastructure; D006056:Golgi Apparatus / Q000382:microbiology* / Q000648:ultrastructure; D014645:Herpesvirus 3, Human / Q000502:physiology* / Q000648:ultrastructure; D006801:Humans; D008168:Lung; D008247:Lysosomes / Q000382:microbiology / Q000648:ultrastructure; D008358:Mannose / Q000378:metabolism; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D008954:Models, Biological; D015388:Organelles / Q000382:microbiology* / Q000648:ultrastructure; D014617:Vacuoles / Q000382:microbiology / Q000648:ultrastructure; D014759:Viral Envelope Proteins / Q000032:analysis / Q000096:biosynthesis; D014909:Wheat Germ Agglutinins
D014759:Viral Envelope Proteins; D014909:Wheat Germ Agglutinins; D008358:Mannose